The story of our antibodies

Sdílet
Vložit
  • čas přidán 25. 04. 2018
  • Therapeutic antibodies have improved treatments of complex diseases such as cancer, viral infections and inflammatory diseases over the past three decades, due to their unique ability to specifically home in on surface proteins.
    A new generation of biologically engineered antibody drugs - bispecifics - combine the binding specificity of two antibodies in only one molecule. Roche has invented the CrossMAb technology to produce bispecific antibodies.
    Find more to this topic: ow.ly/glLB30jGKCX
    Subscribe to our CZcams channel now: czcams.com/users/roche?su...
    Get in touch with us:
    www.roche.com/
    / rochecareers
    / roche
    / roche
    Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
    Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.
    For more information and insights visit: www.roche.com/
  • Věda a technologie

Komentáře • 3